A rifampicin-resistant (rpoB) mutation in Pseudomonas protegens Pf-5 strain leads to improved antifungal activity and elevated production of secondary metabolites. (Record no. 26045187)
[ view plain ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 01468 a2200397 4500 |
| 005 - DATE AND TIME OF LATEST TRANSACTION | |
| control field | 20250517095252.0 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
| fixed length control field | 201703s 0 0 eng d |
| 022 ## - INTERNATIONAL STANDARD SERIAL NUMBER | |
| International Standard Serial Number | 1769-7123 |
| 024 7# - OTHER STANDARD IDENTIFIER | |
| Standard number or code | 10.1016/j.resmic.2016.05.001 |
| Source of number or code | doi |
| 040 ## - CATALOGING SOURCE | |
| Original cataloging agency | NLM |
| Language of cataloging | eng |
| Transcribing agency | NLM |
| 100 1# - MAIN ENTRY--PERSONAL NAME | |
| Personal name | Xie, Yali |
| 264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
| Date of production, publication, distribution, manufacture, or copyright notice | 20170306 |
| 245 00 - TITLE STATEMENT | |
| Title | A rifampicin-resistant (rpoB) mutation in Pseudomonas protegens Pf-5 strain leads to improved antifungal activity and elevated production of secondary metabolites. |
| Medium | [electronic resource] |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
| Name of publisher, distributor, etc. | Research in microbiology |
| Date of publication, distribution, etc. | Oct 2016 |
| 300 ## - PHYSICAL DESCRIPTION | |
| Extent | 625-629 p. |
| Other physical details | digital |
| 500 ## - GENERAL NOTE | |
| General note | Publication Type: Journal Article |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Antibiosis |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Antibiotics, Antitubercular |
| General subdivision | pharmacology |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Antifungal Agents |
| General subdivision | metabolism |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Biological Products |
| General subdivision | metabolism |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Chromatography, High Pressure Liquid |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | DNA-Directed RNA Polymerases |
| General subdivision | genetics |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Drug Resistance, Bacterial |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Mutation, Missense |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Pseudomonas |
| General subdivision | drug effects |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Rifampin |
| General subdivision | pharmacology |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Secondary Metabolism |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Liu, Zhengqiang |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Zhang, Guoyong |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Mo, Xiangtao |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Ding, Xuezhi |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Xia, Liqiu |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Hu, Shengbiao |
| 773 0# - HOST ITEM ENTRY | |
| Title | Research in microbiology |
| Related parts | vol. 167 |
| -- | no. 8 |
| -- | p. 625-629 |
| 856 40 - ELECTRONIC LOCATION AND ACCESS | |
| Uniform Resource Identifier | <a href="https://doi.org/10.1016/j.resmic.2016.05.001">https://doi.org/10.1016/j.resmic.2016.05.001</a> |
| Public note | Available from publisher's website |
No items available.